Pathway Biomed Limited

The August 2006 edition of our Health & Life Science Quarterly Blue Book profiles niche life sciences companies, with a focus on company strategies, key projects and significant milestones.

CyGenics Ltd (ASX: CYN) announced that its wholly-owned subsidiary, Cell Sciences Pte Ltd, has signed an Memorandum of Understanding (MOU) with Rockeby Biomed (ASX: RBY) for logistics, sales, marketing and master distribution of the Avian (bird) and Human Flu Tests for the Singapore, Malaysia, Hong Kong, Indonesia, Myanmar, Cambodia, Philippines and Vietnam markets.

The announcement by Rockeby Biomed (ASX: RBY) on 11 November regarding the company's exclusive marketing and distribution rights to two rapid tests for bird flu has generated considerable interest worldwide. Rockeby has also confirmed it has received the first stock of the test and is expected to begin distribution in South East Asia by 1st December 2005.